Dossier
CRISPR therapies
Coverage of CRISPR therapies in the Nexus archive.
- Personalized CRISPR therapies could soon reach thousands — here’s how
A new approach to trialing CRISPR therapies for rare genetic diseases could make their production economically viable, potentially enabling treatment for thousands. The study, published in Nature, highlights advancements in personalized medicine for genetic disorders.
- Daily briefing: Should we worry about AI doomsday?
The article discusses researchers' perspectives on the validity and risks of AI doomsday scenarios, alongside updates on a social network for agentic AI bots and advancements in personalized CRISPR therapies to expand access.